Robert Balk to Shock, Septic
This is a "connection" page, showing publications Robert Balk has written about Shock, Septic.
Connection Strength
4.031
-
Evaluating the adequacy of fluid resuscitation in patients with septic shock: controversies and future directions. Hosp Pract (1995). 2012 Apr; 40(2):147-57.
Score: 0.392
-
Systemic steroids in severe sepsis and septic shock. Am J Respir Crit Care Med. 2012 Jan 15; 185(2):133-9.
Score: 0.371
-
Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock. 2010 Apr; 33(4):375-80.
Score: 0.341
-
A campaign worth joining: improving outcome in severe sepsis and septic shock using the Surviving Sepsis Campaign guidelines. South Med J. 2007 Jun; 100(6):557-8.
Score: 0.280
-
Choice of vasopressor in septic shock: does it matter? Crit Care. 2007; 11(6):174.
Score: 0.273
-
Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations. Dis Mon. 2004 Apr; 50(4):168-213.
Score: 0.225
-
New treatment strategies for severe sepsis and septic shock. Curr Opin Crit Care. 2003 Oct; 9(5):390-6.
Score: 0.218
-
Steroids for septic shock: back from the dead? (Pro). Chest. 2003 May; 123(5 Suppl):490S-9S.
Score: 0.211
-
Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations. Crit Care Clin. 2000 Apr; 16(2):179-92.
Score: 0.171
-
Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin. 2000 Apr; 16(2):337-52, vii.
Score: 0.171
-
Role of Antithrombin III and Tissue Factor Pathway in the Pathogenesis of Sepsis. Crit Care Clin. 2020 Apr; 36(2):255-265.
Score: 0.169
-
Outcome of septic shock: location, location, location. Crit Care Med. 1998 Jun; 26(6):983-4.
Score: 0.150
-
The New Sepsis Definitions: Implications for Critical Care Practitioners. Am J Crit Care. 2016 Sep; 25(5):457-64.
Score: 0.133
-
Procalcitonin as an Early Marker of the Need for Invasive Respiratory or Vasopressor Support in Adults With Community-Acquired Pneumonia. Chest. 2016 Oct; 150(4):819-828.
Score: 0.130
-
Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: A single-center, before-and-after study. Clin Ther. 2010 Jul; 32(7):1285-93.
Score: 0.087
-
Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med. 1989 May; 17(5):389-93.
Score: 0.080
-
The septic syndrome. Definition and clinical implications. Crit Care Clin. 1989 Jan; 5(1):1-8.
Score: 0.078
-
Low dose ibuprofen reverses the hemodynamic alterations of canine endotoxin shock. Crit Care Med. 1988 Nov; 16(11):1128-31.
Score: 0.077
-
Effects of ibuprofen on neutrophil function and acute lung injury in canine endotoxin shock. Crit Care Med. 1988 Nov; 16(11):1121-7.
Score: 0.077
-
A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987 Sep 10; 317(11):653-8.
Score: 0.071
-
Nitric oxide in the pathogenesis of sepsis. Infect Dis Clin North Am. 1999 Jun; 13(2):449-63, x.
Score: 0.040
-
Therapeutic use of antithrombin concentrate in sepsis. Semin Thromb Hemost. 1998; 24(2):183-94.
Score: 0.037
-
Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med. 2017 Dec; 45(12):2078-2088.
Score: 0.036
-
Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017 Dec; 43(12):1751-1763.
Score: 0.036
-
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med. 1996 Jun 27; 334(26):1697-702.
Score: 0.033
-
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA. 1994 Jun 15; 271(23):1836-43.
Score: 0.029
-
Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993 Oct 15; 119(8):771-8.
Score: 0.027
-
Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men. Crit Care Med. 1991 Aug; 19(8):1060-6.
Score: 0.023
-
Ventilatory support in the management of septic patients. Crit Care Clin. 1989 Jan; 5(1):157-75.
Score: 0.020
-
Alveolar macrophage function in a canine model of endotoxin-induced lung injury. Am Rev Respir Dis. 1986 Oct; 134(4):745-51.
Score: 0.017
-
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med. 1997 Jul; 25(7):1115-24.
Score: 0.009
-
Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA. 1995 Mar 22-29; 273(12):934-41.
Score: 0.007
-
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992 Jun; 101(6):1644-55.
Score: 0.006
-
Prostaglandins, cyclo-oxygenase inhibitors, and thromboxane synthetase inhibitors in the pathogenesis of multiple systems organ failure. Crit Care Clin. 1989 Apr; 5(2):303-14.
Score: 0.005